Clin2
NCT06496997Likely a fitRecruiting

Steroid treatment for acute lung failure (ARDS) trial

Acute Respiratory Distress Syndrome

Treatments studied

Part of Lungs & breathing clinical trials.

This study tests if adding a type of steroid (glucocorticoid) to standard treatment helps people on a breathing machine recover from severe lung failure (ARDS). It compares different doses to see which works best.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 2/Phase 3
Enrollment
300 people
Ages
Any age
Study type
Interventional

Who can take part

  • You have a sudden, severe lung problem called ARDS (acute respiratory distress syndrome).
  • You need a breathing machine to help you breathe.
  • Your oxygen levels have been very low in the last 48 hours.
  • Chest x-rays or CT scans show cloudy areas in both lungs.
  • Your breathing symptoms started or got worse within the last 7 days.
  • Heart failure is not the main cause of your breathing problem.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07511582Recruiting· Phase 2
Steroids for severe breathing problems in the ICU

This study tests whether a corticosteroid (a type of anti-inflammatory medicine) can help people with severe breathing problems or serious infections who have a specific 'hyperinflammatory' pattern. If you are in the ICU on a ventilator, this trial may be an option for you.

Beijing, Beijing Municipality
NCT06387823Recruiting
Testing Sivelestat Sodium and Dexamethasone for Severe ARDS

This trial tests a combination of two medicines (Sivelestat Sodium and Dexamethasone) to see if they can help people with severe lung injury (ARDS) who need a breathing machine. It is for patients whose condition has just worsened and who are on a ventilator early in their illness.

Beijing, Beijing Municipality
NCT06703073Recruiting· Phase 2
Testing new treatments for acute respiratory distress syndrome (ARDS)

This trial is testing new treatments for people with ARDS, a serious lung condition. The goal is to find therapies that help patients breathe better and recover faster. If you or a loved one has ARDS, this study may offer access to experimental treatments.

Birmingham, Alabama
NCT06640777Not yet recruiting· Phase 3
Testing a new drug for severe lung injury

This trial tests a new drug called LEAF-4L6715 to see if it helps people with severe acute respiratory distress syndrome (ARDS), a serious lung condition. If you are on a breathing machine and meet the criteria below, you may be able to join.

Paris, Paris
NCT04545242Recruiting· Phase 4
Dexamethasone for severe lung failure from infections on ventilators

This trial studies whether dexamethasone (a steroid medicine) improves outcomes in adults who have sudden, severe breathing failure caused by an infection while they are on a breathing machine. It may help reduce inflammation in the lungs during critical illness.

Terrassa, Barcelona
NCT07576660Not yet recruiting· Phase 3
Dexamethasone for lung injury from sepsis

This trial tests whether the steroid dexamethasone can help people with sepsis who develop acute respiratory distress syndrome (ARDS), a severe lung injury. If you have an infection and need breathing support, this study may help find a better treatment.

Nanjing, Jiangsu

Hear when a new Acute Respiratory Distress Syndrome trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.